Journal articles: 'Somnolence'

1

Covassin, Naima, and Virend K. Somers. "Somnolence." Hypertension 68, no. 5 (November 2016): 1100–1102. http://dx.doi.org/10.1161/hypertensionaha.116.07073.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Billiard, M. "Somnolence." Médecine du Sommeil 1, no. 2 (December 2004): 1. http://dx.doi.org/10.1016/s1769-4493(04)70170-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Tavares, Stella, Flávio Alóe, Valentim Gentil, and Milberto Scaff. "Excessive somnolence." Sao Paulo Medical Journal 114, no. 4 (August 1996): 1231–38. http://dx.doi.org/10.1590/s1516-31801996000400008.

Full text

Abstract:

Excessive somnolence can be quite a incapacitating manifestation, and is frequently neglected by physicians and patients. This article reviews the determinant factors, the evaluation and quantification of diurnal somnolence, and the description and treatment of the main causes of excessive somnolence.

APA, Harvard, Vancouver, ISO, and other styles

4

Petiau, C., and J. Krieger. "Somnolence diurne pathologique." La Revue de Médecine Interne 18, no. 3 (March 1997): 210–18. http://dx.doi.org/10.1016/s0248-8663(97)89297-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

SHUSTER, JOEL. "Pramipexole and somnolence." Nursing 30, no. 8 (August 2000): 81. http://dx.doi.org/10.1097/00152193-200030080-00039.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Ryan, Janis. "Radiation Somnolence Syndrome." Journal of Pediatric Oncology Nursing 17, no. 1 (January 2000): 50–53. http://dx.doi.org/10.1177/104345420001700107.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Billiard, Michel, and Yves Dauvilliers. "Somnolence et psychiatrie." EMC - Psychiatrie 1, no. 1 (January 2004): 1–6. http://dx.doi.org/10.1016/s0246-1072(03)00111-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Salthun-Lassalle, Bénédicte. "Alzheimer : combattre la somnolence." Cerveau & Psycho N° 145, no. 7 (July 8, 2022): 12. http://dx.doi.org/10.3917/cerpsy.145.0012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Arnulf, Isabelle. "Somnolence et maladies neurologiques." Revue Neurologique 178 (April 2022): S175—S176. http://dx.doi.org/10.1016/j.neurol.2022.02.101.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Besset, A. "Exploration de la somnolence." Médecine du Sommeil 1, no. 2 (December 2004): 15–21. http://dx.doi.org/10.1016/s1769-4493(04)70172-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Bayon, V., and D. Léger. "Sommeil, somnolence et travail." Médecine du Sommeil 5, no. 18 (December 2008): 10–14. http://dx.doi.org/10.1016/s1769-4493(08)70186-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Monaca, C. "Somnolence et syndromes parkinsoniens." Revue Neurologique 164, no. 12 (December 2008): F253—F262. http://dx.doi.org/10.1016/s0035-3787(08)75126-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Léger, Damien, and Philippe Ement. "Somnolence et risque accidentel." La Presse Médicale 44, no. 10 (October 2015): 1022–28. http://dx.doi.org/10.1016/j.lpm.2015.04.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Haba-Rubio, J., and J. Krieger. "Somnolence, fatigue et hypersomnie." Médecine du Sommeil 8, no. 1 (January 2011): 5–14. http://dx.doi.org/10.1016/j.msom.2011.01.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Palot, A. "Somnolence résiduelle sous PPC." Médecine du Sommeil 9, no. 3 (July 2012): 119–22. http://dx.doi.org/10.1016/j.msom.2012.06.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Jouvet, M. "La somnolence. Modèles expérimentaux." Neurophysiologie Clinique/Clinical Neurophysiology 23, no. 4 (July 1993): 291–303. http://dx.doi.org/10.1016/s0987-7053(05)80122-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Guilleminault, C., R. Stoohs, and A. Clerk. "Daytime somnolence: therapeutic approaches." Neurophysiologie Clinique/Clinical Neurophysiology 23, no. 1 (January 1993): 23–33. http://dx.doi.org/10.1016/s0987-7053(05)80280-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Mullens, E. "Somnolence au volant : danger." Neurophysiologie Clinique/Clinical Neurophysiology 28, no. 2 (May 1998): 178–79. http://dx.doi.org/10.1016/s0987-7053(98)80082-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Ondzé, B., V. Charlot, F. Espa, A. Besset, and M. Billiard. "Intérêt de l'échelle de somnolence d'Epworth (ESS) dans l'évaluation de la somnolence." Neurophysiologie Clinique/Clinical Neurophysiology 28, no. 2 (May 1998): 177–78. http://dx.doi.org/10.1016/s0987-7053(98)80080-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Eugene, Andy R. "Association of sleep among 30 antidepressants: a population-wide adverse drug reaction study, 2004–2019." PeerJ 8 (March 11, 2020): e8748. http://dx.doi.org/10.7717/peerj.8748.

Full text

Abstract:

Background Sleep is one of the most essential processes required to maintain a healthy human life, and patients experiencing psychiatric illness often experience an inability to sleep. The aim of this study is to test the hypothesis that antidepressant compounds with strong binding affinities for the serotonin 5-HT2C receptor, histamine H1 receptors, or norepinephrine transporter (NET) will be associated with the highest odds of somnolence. Methods Post-marketing cases of patient adverse drug reactions were obtained from the United States Food and Drug Administration Adverse Events Reporting System (FAERS) during the reporting window of January 2004 to September 2019. Disproportionality analyses of antidepressants reporting somnolence were calculated using the case/non-case method. The reporting odds-ratios (ROR) and corresponding 95% confidence interval (95% CI) were computed and all computations and graphing conducted in R. Results There were a total of 69,196 reported cases of somnolence out of a total of 7,366,864 cases reported from January 2004 to September 2019. Among the 30 antidepressants assessed, amoxapine (n = 16) reporting odds-ratio (ROR) = 7.1 (95% confidence interval [CI] [4.3–11.7]), atomoxetine (n = 1,079) ROR = 6.6 (95% CI [6.2–7.1]), a compound generally approved for attention deficit hyperactivity disorder (ADHD), and maprotiline (n = 18) ROR = 6.3 (95% CI, 3.9–10.1) were the top three compounds ranked with the highest reporting odds of somnolence. In contrast, vortioxetine (n = 52) ROR = 1.3 (95% CI [1.0–1.8]), milnacipran (n = 58) ROR = 2.1 (95% CI [1.7–2.8]), and bupropion (n = 1,048) ROR = 2.2 (95% CI [2.1–2.4]) are least significantly associated with somnolence. Moreover, levomilnacipran (n = 1) ROR = 0.4 (95% CI [0.1–2.9]) was not associated with somnolence. Conclusion Among the thirty tested antidepressants, consistent with the original hypothesis, amoxepine has strongest 5-HT2C receptor binding affinity and has the highest reporting odds of somnolence. Atomoxetine, ranked second in reporting odds of somnolence overall, binds to the NET with with the strongest binding affinity among the thirty compounds. Mirtazapine, a tetracyclic antidepressant, was ranked 11th in reporting odds of somnolence and had the strongest H1 receptor binding affinity. This study provides an informative ranking of somnolence among thirty antidepressant compounds with an already wide array of clinical indications as well as provides insight into potential drug repurposing in psychopharmacology.

APA, Harvard, Vancouver, ISO, and other styles

21

Generali, Joyce A., and Dennis J. Cada. "Modafinil: Parkinson Disease–Related Somnolence." Hospital Pharmacy 49, no. 7 (July 2014): 612–14. http://dx.doi.org/10.1310/hpj4907-612.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Vecchierini, M. F. "Comment évaluer la somnolence diurne ?" Revue des Maladies Respiratoires 23 (June 2006): 97–101. http://dx.doi.org/10.1016/s0761-8425(06)72485-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Rioufol, Marie-Odile. "Le sommeil et la somnolence." Soins Aides-Soignantes 10, no. 55 (November 2013): 10–11. http://dx.doi.org/10.1016/j.sasoi.2013.10.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Dement, WC, and M. Gelb. "Somnolence: its importance in society." Neurophysiologie Clinique/Clinical Neurophysiology 23, no. 1 (January 1993): 5–14. http://dx.doi.org/10.1016/s0987-7053(05)80278-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

EdD, Ethel Mitty, and Sandi Flores. "Sleepiness or Excessive Daytime Somnolence." Geriatric Nursing 30, no. 1 (January 2009): 53–60. http://dx.doi.org/10.1016/j.gerinurse.2008.11.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Lemoine, P., and A. Nicolas. "La malveille. Hypersomnie, somnolence, clinophilie." Annales Médico-psychologiques, revue psychiatrique 162, no. 1 (February 2004): 64–67. http://dx.doi.org/10.1016/j.amp.2003.12.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Desautels, Alex, Antonio Zadra, Marc-Antoine Labelle, Yves Dauvilliers, Dominique Petit, and Jacques Montplaisir. "Daytime somnolence in adult sleepwalkers." Sleep Medicine 14, no. 11 (November 2013): 1187–91. http://dx.doi.org/10.1016/j.sleep.2013.04.029.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Phillips, M. F., H. M. Steer, J. R. Soldan, C. M. Wiles, and P. S. Harper. "Daytime somnolence in myotonic dystrophy." Journal of Neurology 246, no. 4 (April 29, 1999): 275–82. http://dx.doi.org/10.1007/s004150050346.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Martensen, Robert L. "The Somnolence of Sleep Research." JAMA: The Journal of the American Medical Association 274, no. 20 (November 22, 1995): 1643. http://dx.doi.org/10.1001/jama.1995.03530200081054.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Montastruc, Jean-Louis, and Olivier Rascol. "Modafinil and pramipexole-associated somnolence." Movement Disorders 16, no. 4 (2001): 783. http://dx.doi.org/10.1002/mds.1146.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Phattanarudee, Siripan, Sunisa Sangthong, and Roongroj Bhidayasiri. "Association between Sleep Disturbances and Daytime Somnolence in Parkinson’s Disease." European Neurology 80, no. 5-6 (2018): 268–76. http://dx.doi.org/10.1159/000496937.

Full text

Abstract:

Background: Sleep disturbance is a common problem among patients with Parkinson’s disease (PD). Objectives: To investigate the prevalence of daytime somnolence and night-time sleep disturbances; to characterise the night-time sleep disturbance in patients with daytime somnolence; and to determine the correlation between daytime somnolence and night-time sleep disturbances. Methods: One hundred and sixty patients with PD were included in the study. Each patient completed the Thai version of the Epworth Sleepiness Scale (ESS) questionnaire to evaluate excessive daytime sleepiness (EDS), and the PD Sleep Scale version-2 (PDSS-2) questionnaire to evaluate night-time sleep disturbance. Subjective sleep information and details about the presence or absence of sleep attack (SA) were also obtained from the patients. Results: The types of daytime somnolence found in this study were EDS, SA, and combination of EDS and SA (EDS + SA) with the prevalence rates of 22.5, 3.1 and 6.3%, respectively. The prevalence of night-time sleep disturbance was 46.9%. The most common nocturnal disturbance (82.5%) was “get up at night to pass urine”. There was a significant positive correlation between the ESS score and PDSS-2 total score with a correlation coefficient of 0.16 (p = 0.043). Patients with “EDS + SA” were the most affected by nocturnal disturbances, as they represented the largest group among those patients with night-time disturbances and had the highest PDSS-2 total score (p < 0.05). Conclusion: There are differences in nocturnal sleep disturbances among PD patients with different types of daytime somnolence. The significant positive correlation between the ESS and the PDSS-2 total scores suggests that night-time sleep disturbance may influence daytime somnolence.

APA, Harvard, Vancouver, ISO, and other styles

32

Pérez-Chada, Daniel, Sergio Arias Bioch, Daniel Schönfeld, David Gozal, and Santiago Perez-Lloret. "Screen use, sleep duration, daytime somnolence, and academic failure in school-aged adolescents." PLOS ONE 18, no. 2 (February 14, 2023): e0281379. http://dx.doi.org/10.1371/journal.pone.0281379.

Full text

Abstract:

In this study, we examined the relationship between screen time use, sleep characteristics, daytime somnolence, and academic performance in school-aged adolescents. We surveyed 1,257 12- to 18-year-old adolescents attending 52 schools in urban or suburban areas of Argentina. We recorded the daily exposure to various screen-based activities, including video- and online-gaming, social media, TV or streaming. Screen time and device type in the hour before bedtime, sleep patterns during weekdays and weekends, somnolence (Pediatric Daytime Sleepiness Scale score), and grades in language and mathematics were also assessed. Structural Equation Modelling was used to identify a path connecting the latent variables. Results are expressed as standardized regression weights (srw). Missing data were present in 393 subjects, and thus the final sample consisted of 864 complete responses. Daytime somnolence (i.e., PDSS score ≥ 15) was observed in 614 participants (71%), and academic failure (i.e., grades < 7/10) in 352 of them (41%). Time spent using video gaming consoles was negatively associated with sleep duration (srw = -0.22, p<0.01) and positively connected with daytime somnolence (srw = 0.11, p<0.01). Use of mobile devices was associated with lower academic performance (srw = -0.11, p<0.01). Sleep duration was inversely related to daytime somnolence (srw = -0.27, p<0.01), which was in turn negatively associated with academic performance (srw = -0.18, p<0.05). Bedtime computer use did not influence any outcome. In summary, among adolescents, screen use adversely affected nighttime sleep, daytime somnolence, and academic performance. These findings call for the implementation of educational public campaigns aimed at promoting healthy sleep and reducing screen exposure among adolescents.

APA, Harvard, Vancouver, ISO, and other styles

33

&NA;. "Loratadine causes less somnolence than cetirizine." Reactions Weekly &NA;, no. 809 (July 2000): 5. http://dx.doi.org/10.2165/00128415-200008090-00006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Hamano, Tadanori, Tomoko Yamamoto, Isamu Miyamori, and Masaru Kuriyama. "Hyponatremia with somnolence due to indapamide." Rinsho Shinkeigaku 48, no. 1 (2008): 52–55. http://dx.doi.org/10.5692/clinicalneurol.48.52.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Rodenstein, D. "What is this thing called somnolence?" European Respiratory Journal 38, no. 1 (June 30, 2011): 7–8. http://dx.doi.org/10.1183/09031936.00177010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Sallèles, Eve, Fabienne Ory-Magne, Benaiteau Marie, Michel Tiberge, Rachel Debs, and Jeremie Pariente. "Y02 Un cas de somnolence inhabituelle." Revue Neurologique 175 (April 2019): S44. http://dx.doi.org/10.1016/j.neurol.2019.01.137.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Dyken, Mark E., and Thoru Yamada. "Narcolepsy and Disorders of Excessive Somnolence." Primary Care: Clinics in Office Practice 32, no. 2 (June 2005): 389–413. http://dx.doi.org/10.1016/j.pop.2005.02.012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Carrot, B. "Assessing daytime somnolence in child psychopathology." Neuropsychiatrie de l'Enfance et de l'Adolescence 60, no. 5 (July 2012): S96. http://dx.doi.org/10.1016/j.neurenf.2012.05.401.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Morison, Alexander. "Somnolence with Cyanosis Cured by Massage." Obesity Research 2, no. 4 (July 1994): 387–88. http://dx.doi.org/10.1002/j.1550-8528.1994.tb00082.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Hauser, Robert A., Mervat N. Wahba, Theresa A. Zesiewicz, and W. McDowell Anderson. "Modafinil treatment of pramipexole-associated somnolence." Movement Disorders 15, no. 6 (November 2000): 1269–71. http://dx.doi.org/10.1002/1531-8257(200011)15:6<1269::aid-mds1036>3.0.co;2-r.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Gafina, Guzel, and Marc Spielmanns. "Chronisch-obstruktive Lungenerkrankung: Verbesserung von Schlaf und Tagesmüdigkeit durch pneumologische Rehabilitation." Kompass Pneumologie 8, no. 4 (2020): 200–201. http://dx.doi.org/10.1159/000509251.

Full text

Abstract:

Background: Dyspnea, fatigue, and decline in sleep quality are symptoms of chronic obstructive pulmonary disease (COPD). Pulmonary rehabilitation programs have been shown to ameliorate dyspnea and fatigue. However, only a few studies have investigated the effects of pulmonary rehabilitation on the sleep quality of COPD patients. In this study, we analyzed the benefits of a pulmonary rehabilitation program to sleep quality and daytime somnolence in COPD patients. Methods: This study was a study of 30 moderate-severe COPD patients. All patients were evaluated by a pulmonologist and underwent polysomnography before participating in the study. For this study, we selected only ex-smokers and patients with sleep apnea were referred to the sleep clinic. These participants were prospectively recruited and not selected based on program completion. Before the start of the program, sleep quality and daytime somnolence of the participants were evaluated using the Pittsburgh Sleep Quality Index (PSQI) and the Epworth Sleepiness Scale (ESS), respectively. Rehabilitation program consisted of muscular training sessions conducted at the gym 3 times per week for 12 weeks. After rehabilitation program, the patients were reassessed and their sleep quality and daytime somnolence were reevaluated using the PSQI and the ESS, respectively. Results: Before rehabilitation, PSQI evaluation revealed that 73% of the participants had poor sleep quality, and ESS evaluation showed that 86.7% of the participants experienced daytime somnolence. After pulmonary rehabilitation, the PSQI specifically improved in terms of subjective sleep quality and sleep duration (< 0.001), habitual sleep efficiency (0.001), and sleep latency and sleep alterations (0.002) and there was also improvement in the ESS (< 0.001). Conclusion: Pulmonary rehabilitation program of gradually increasing intensity has the potential to provide sleep-related benefits to patients with COPD who have poor sleep quality and daytime somnolence. Trial registration: Registro Brasileiro de Ensaios Clínicos (ReBEC) RBR62b4z2.

APA, Harvard, Vancouver, ISO, and other styles

42

Lopez, R. "Liens entre TDA/H à l’âge adulte et narcolepsie et hypersomnie idiopathique." European Psychiatry 29, S3 (November 2014): 589. http://dx.doi.org/10.1016/j.eurpsy.2014.09.305.

Full text

Abstract:

Les hypersomnies centrales (narcolepsie avec cataplexie [NC], narcolepsie sans cataplexie [NSC] et hypersomnie idiopathique [HI]) sont des troubles du sommeil invalidants responsables d’une somnolence diurne excessive (SDE). L’expérience clinique et les données de la littérature suggèrent que les symptômes du Trouble Déficit d’Attention avec ou sans Hyperactivité (TDA/H) sont fréquemment observés dans les hypersomnies centrales.Les hypothèses physiopathologiques concernant cette association sont discutées : s’agit-il de conséquences de la somnolence diurne excessive ou le reflet d’une vulnérabilité commune entre les hypersomnies et le TDA/H.Afin d’amener des pistes de réponse, seront présentées les données préliminaires de travaux portant sur (1) l’évaluation du TDA/H dans une cohorte de sujets souffrant d’hypersomnie centrale ; (2) la fréquence de la somnolence diurne excessive dans une cohorte d’adultes souffrant de TDA/H. Une meilleure compréhension de cette association peut conduire au développement de stratégies thérapeutiques innovantes ciblant les symptômes de TDA/H dans les hypersomnies centrales d’une part, et le déficit de vigilance dans le TDA/H d’autre part.

APA, Harvard, Vancouver, ISO, and other styles

43

Davenport, Jennifer D., Michelle W. McCarthy, and Marcia L. Buck. "Excessive Somnolence from Aripiprazole in a Child." Pharmacotherapy 24, no. 4 (April 2004): 522–25. http://dx.doi.org/10.1592/phco.24.5.522.33352.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Ballesteros-Zebadua, Paola, Anahi Chavarria, Miguel Angel Celis, Carlos Paz, and Javier Franco-Perez. "Radiation-Induced Neuroinflammation and Radiation Somnolence Syndrome." CNS & Neurological Disorders - Drug Targets 11, no. 7 (December 1, 2012): 937–49. http://dx.doi.org/10.2174/1871527311201070937.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Esnaud, R., W. Trzepizur, Y. Dauvilliers, S. Launois, and J. L. Pépin. "Le pneumologue face à la somnolence diurne." Revue des Maladies Respiratoires Actualités 13, no. 1 (June 2021): 1S118–1S120. http://dx.doi.org/10.1016/s1877-1203(21)00073-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Sanjiv, C. C., M. Schulzer, E. Mak, J. Fleming, W. R. W. Martin, T. Brown, S. M. Calne, et al. "Daytime somnolence in patients with Parkinson's disease." Parkinsonism & Related Disorders 7, no. 4 (October 2001): 283–86. http://dx.doi.org/10.1016/s1353-8020(00)00076-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Billiard, M. "Diagnostic d’une somnolence diurne excessive chez l’adulte." Médecine du Sommeil 1, no. 2 (December 2004): 5–14. http://dx.doi.org/10.1016/s1769-4493(04)70171-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Dervaux, A., and X. Laqueille. "Substances addictives, troubles du sommeil et somnolence." Médecine du Sommeil 1, no. 2 (December 2004): 23–27. http://dx.doi.org/10.1016/s1769-4493(04)70173-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Fresco, J. P., S. H. Launois, S. M. Lado, and A. Pajon. "Somnolence diurne excessive et dépression : données polysomnographiques." Médecine du Sommeil 10, no. 1 (January 2013): 19–28. http://dx.doi.org/10.1016/j.msom.2012.10.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Shiber, Joseph, Emily Fontane, and Margaret Rosier. "A 6-Year-Old Girl With Somnolence." Pediatric Emergency Care 23, no. 12 (December 2007): 909–11. http://dx.doi.org/10.1097/pec.0b013e31815d3b77.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Journal articles on the topic 'Somnolence'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles